[Sertraline-induced chronic eosinophilic pneumonia].

Pneumopathie chronique à éosinophiles induite par la sertraline.
Depression Drug-induced lung disease Dépression Inhibiteurs de la recapture de la sérotonine Pneumonie à éosinophiles Pneumopathie médicamenteuse Pulmonary eosinophilia Serotonin reuptake inhibitors Sertraline

Journal

Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 10 05 2020
accepted: 05 10 2020
pubmed: 15 2 2021
medline: 31 8 2021
entrez: 14 2 2021
Statut: ppublish

Résumé

Sertraline is a selective serotonin reuptake inhibitor which is often used as first-line treatment for depression. Several patterns of interstitial lung disease attributable to sertraline have been reported in the literature. A 69-year-old patient, who had been taking sertraline to treat severe depression for 10 months, presented with a deterioration in his general condition and respiratory symptoms found to be associated with bilateral pneumonitis. An exhaustive assessment did not reveal any infectious or autoimmune aetiology. Transthoracic lung biopsy revealed a pattern of eosinophilic lung disease. Sertraline-induced lung toxicity was then suspected and this treatment was therefore stopped. The patient's symptoms resolved and the chest imaging normalized. Our observation suggests that sertraline was the cause of chronic eosinophilic pneumonia characterized by an insidious clinical presentation several months after starting the medication. Given its widespread prescription, we encourage any clinician facing this disease to pay attention to possible drug-induced origins of lung disease.

Identifiants

pubmed: 33581985
pii: S0761-8425(20)30378-8
doi: 10.1016/j.rmr.2020.11.012
pii:
doi:

Substances chimiques

Serotonin Uptake Inhibitors 0
Sertraline QUC7NX6WMB

Types de publication

Case Reports Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

210-214

Informations de copyright

Copyright © 2020 SPLF. Published by Elsevier Masson SAS. All rights reserved.

Auteurs

P Brancaleone (P)

Service de pneumologie, centres hospitaliers Jolimont, 7100 La Louvière, Belgique. Electronic address: pierre.brancaleone@gmail.com.

O Descamps (O)

Service de médecine interne, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.

M Piquet (M)

Service de pneumologie, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.

G Detry (G)

Laboratoire de biologie clinique, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.

M Mignon (M)

Service de radiologie, centres hospitaliers Jolimont, 7100 La Louvière, Belgique.

B Weynand (B)

Service d'anatomopathologie, universitair ziekenhuis Leuven-Gasthuisberg, 3000 Leuven, Belgique.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH